-
公开(公告)号:AU7050101A
公开(公告)日:2001-11-20
申请号:AU7050101
申请日:2001-05-03
Applicant: BASF AG
Inventor: HAHNLEIN WOLFGANG , KRAMER KLAUS , HASSELWANDER OLIVER , SCHWEIKERT LONI
IPC: A23L1/30 , A23C9/158 , A23K1/16 , A23L1/305 , A23L2/52 , A23L33/00 , A23L33/15 , A61K31/4415 , A61K31/519 , A61K31/7076 , A61K31/714 , A61P9/00 , A61P25/00 , C07D475/04 , A23L1/302
Abstract: Compositions are proposed which comprise folic acid in combination with 5-methyltetrahydrofolic acid, and also compositions which comprise folic acid, 5-methyltetrahydrofolic acid and/or 5-methyltetrahydrofolylpolyglutamate and also comprise a dietary component and/or a nutrient preparation, and their use is also proposed.
-
公开(公告)号:AU6742401A
公开(公告)日:2001-11-20
申请号:AU6742401
申请日:2001-05-10
Applicant: BASF AG
Inventor: HAHNLEIN WOLFGANG , KRAMER KLAUS , HASSELWANDER OLIVER , MULLER WALTER E , ECKERT GUNTHER P
IPC: C07D339/04 , A61K31/385 , A61K31/519 , A61K31/7076 , A61K45/00 , A61P25/00 , A61P25/24 , A61P25/28 , C07D475/04 , C07H19/16
Abstract: The present invention relates to the use of lipoic acid and C1 donors, in particular S-adenosylmethionine and/or 5-methyltetrahydrofolate, for the treatment of central nervous system disorders, to compositions with a corresponding active ingredient combination and to compositions in the form of commercial packs with corresponding combination products or single component products for combined use.
-
公开(公告)号:FR2730933B1
公开(公告)日:1999-02-05
申请号:FR9601680
申请日:1996-02-12
Applicant: BASF AG
Inventor: BIERDEL WILKOMMEN ELVIRA , SAMBALE CLEMENS , HAHNLEIN WOLFGANG
IPC: A23K20/174 , A61K8/11 , A61K8/65 , A61K9/48 , C08J3/12
Abstract: Soft gelatin capsules consisting of capsule shell and capsule filling, where the capsule filling comprises one or more water-insoluble active ingredients) in the form of a powdered product.
-
公开(公告)号:AU782556B2
公开(公告)日:2005-08-11
申请号:AU7050101
申请日:2001-05-03
Applicant: BASF AG
Inventor: HAHNLEIN WOLFGANG , KRAMER KLAUS , HASSELWANDER OLIVER , SCHWEIKERT LONI
IPC: A23L1/30 , A23C9/158 , A23K1/16 , A23L1/305 , A23L2/52 , A23L33/00 , A23L33/15 , A61K31/4415 , A61K31/519 , A61K31/7076 , A61K31/714 , A61P9/00 , A61P25/00 , C07D475/04 , A23L1/302
Abstract: Compositions are proposed which comprise folic acid in combination with 5-methyltetrahydrofolic acid, and also compositions which comprise folic acid, 5-methyltetrahydrofolic acid and/or 5-methyltetrahydrofolylpolyglutamate and also comprise a dietary component and/or a nutrient preparation, and their use is also proposed.
-
公开(公告)号:CA2408401A1
公开(公告)日:2002-11-06
申请号:CA2408401
申请日:2001-05-03
Applicant: BASF AG
Inventor: HASSELWANDER OLIVER , SCHWEIKERT LONI , HAHNLEIN WOLFGANG , KRAMER KLAUS
IPC: A23L1/30 , A23C9/158 , A23K1/16 , A23L1/305 , A23L2/52 , A23L33/00 , A23L33/15 , A61K31/4415 , A61K31/519 , A61K31/7076 , A61K31/714 , A61P9/00 , A61P25/00 , C07D475/04 , A23L1/302 , A23L1/29
Abstract: Compositions containing folic acid in combination with 5-methyltetrahydrofol ic acid are disclosed, as well as compositions containing folic acid, 5- methyltetrahydrofolic acid and/or 5-methyltetrahydrofolic acid polyglutamate and a dietary component and/or a dietary preparation and the use thereof.
-
公开(公告)号:CA2408666A1
公开(公告)日:2002-11-08
申请号:CA2408666
申请日:2001-05-10
Applicant: BASF AG
Inventor: MULLER WALTER E , HASSELWANDER OLIVER , KRAMER KLAUS , HAHNLEIN WOLFGANG , ECKERT GUNTHER P
IPC: C07D339/04 , A61K31/385 , A61K31/519 , A61K31/7076 , A61K45/00 , A61P25/00 , A61P25/24 , A61P25/28 , C07D475/04 , C07H19/16
Abstract: The present invention relates to the use of lipoic acid and C1 donors, in particular S-adenosylmethionine and/or 5-methyltetrahydrofolate, for the treatment of central nervous system disorders, to compositions with a corresponding active ingredient combination and to compositions in the form of commercial packs with corresponding combination products or single component products for combined use.
-
7.
公开(公告)号:AU1540602A
公开(公告)日:2002-05-09
申请号:AU1540602
申请日:2002-02-04
Applicant: BASF AG
Inventor: HAHNLEIN WOLFGANG , TOBIASEN ANNE GRETHE , OLESEN JES ELENIUS , HANSEN MORTEN MOHR
IPC: A61K9/107 , A61K9/14 , A61K31/07 , A61K31/122 , A61K31/136 , A61K31/355 , A61K31/45 , A61K31/592 , A61K31/593 , A61P3/02 , A61P39/00
-
8.
公开(公告)号:AU4099197A
公开(公告)日:1998-04-23
申请号:AU4099197
申请日:1997-10-14
Applicant: BASF AG
Inventor: HAHNLEIN WOLFGANG , HANSEN MORTEN MOHR , OLESEN JES ELENIUS , TOBIASEN ANNE GRETHE
IPC: A23K1/16 , A23K20/174 , A23L1/00 , A23L33/15 , A61K9/107 , A61K9/14 , A61K31/07 , A61K31/12 , A61K31/122 , A61K31/355 , A61K31/59 , A61P3/02 , B01J13/00 , A61K31/045
Abstract: Production of a stable vitamin emulsion or dry powder comprises forming an emulsion (A), in the presence of at least 1 protective colloid (C); and optionally (D) at least 1 sugar and/or sugar alcohol and/or other additives (E). When a powder is required, the emulsion is dried, optionally in the presence of a coating material. (A) is (A1)-(A4). (A1) contains vitamin K, vitamin D, vitamin E, and vitamin A or an inert oil, (or a mixture of vitamin A and an inert oil); (A2) contains vitamin K, vitamin D and vitamin A; and (A3) contains vitamin K, vitamin E, and vitamin A; and (A4) contains vitamin D, vitamin E, and vitamin A. The emulsions and powders may also be obtained by separately forming an emulsion of vitamin K and one of (B1), (B2) and (A4) (where both emulsions contain (C) and optionally (D) and (E)) in water, and mixing to give an emulsion (A). (B1) contains a mixture of vitamins A and D; and (B2) contains vitamin A and E. Emulsions containing vitamin D are obtained by dissolving vitamin D in an inert oil and/or vitamin A, and mixing with the other components; or mixing the other components, and mixing with vitamin D. Also claimed are the stable emulsions and powders, and foodstuffs, pharmaceuticals and animal feeds containing the emulsions or powders.
-
公开(公告)号:FR2730933A1
公开(公告)日:1996-08-30
申请号:FR9601680
申请日:1996-02-12
Applicant: BASF AG
Inventor: BIERDEL WILKOMMEN ELVIRA , SAMBALE CLEMENS , HAHNLEIN WOLFGANG
IPC: A23K20/174 , A61K8/11 , A61K8/65 , A61K9/48 , C08J3/12
Abstract: Soft gelatin capsules consisting of capsule shell and capsule filling, where the capsule filling comprises one or more water-insoluble active ingredients) in the form of a powdered product.
-
-
-
-
-
-
-
-